Serving the
Biotechnology and
Pharmaceutical
Industries
 
 
 

CLÆRITY® is easy-to-use web-based software for investigation and management of potential safety signals in adverse event data:

  • Detect and investigate signals
    • What are the significant signals for a drug, class, or group?
    • Is the signal strength changing over time?
    • Is the signal part of a bystander effect or a drug-drug interaction?
    • How do safety profiles of similar drugs compare?

  • Manage and monitor signal investigation workflow
    • Classify signals of interest
    • Track and monitor selected signals over time
    • Document actions and decisions
    • Generate summary status and detailed signal history reports

CLÆRITY Benefits

  • Signal investigation for multiple SRS databases, including: FDA AERS, FDA VAERS and Internal Company SRS Data
  • Detect and investigate potential safety signals
  • Manage and monitor signals of interest over time
  • Document and track outstanding actions
  • Use complementary data mining technologies (PVmaps®, PRR, MGPS) for full coverage

CLÆRITY Products and Services

  • CLÆRITY License: ProSanos offers flexible software licensing options to suit the specific safety information needs of both large and small pharmaceutical companies.
  • CLÆRITY-based service
    • Ongoing surveillance, based on new releases of underlying SRS data sources
    • In-depth, historical characterization of the safety profile of a drug or drug class
    • "Clean" version of AERS data, including drug name normalization and mapping of obsolete MedDRA Terms
    • Reference Event Database containing up-to-date literature references found for a specific drug and/or adverse event

To see real case studies using CLÆRITY, visit our PVmap of the Week



CLÆRITY is a next-generation drug safety software product that can be used to investigate questions about the safety of a particular drug, class of drugs, or therapeutic area.


For more information .


Related Links